D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002 SHANGHAI, Jan. 19, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology… CISION PRNewswireJanuary 19, 2026
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 19, 2026 /PRNewswire/ — Harbour BioMed… CISION PRNewswireJanuary 19, 2026
CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ — CNP Global Co., Ltd. is… CISION PRNewswireJanuary 19, 2026
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership SHANGHAI, Jan. 19, 2026 /PRNewswire/ — WuXi AppTec, a leading global pharmaceutical… CISION PRNewswireJanuary 19, 2026
Press Release A Smarter New Year's Resolution: Investing in Eye Comfort for Screen Heavy Workdays SYDNEY, Jan. 19, 2026 /PRNewswire/ — As the new year begins, many… CISION PRNewswireJanuary 19, 2026
Press Release Elliott Opposes Toyota Fudosan's Revised Tender Offer for Toyota Industries Corporation Elliott, the largest independent shareholder of Toyota Industries, believes the revised tender… CISION PRNewswireJanuary 19, 2026
Press Release Taptouch Introduces Australia's First Locally Built Embedded Payments POS SYDNEY, Jan. 19, 2026 /PRNewswire/ — Taptouch Software, an Australian-owned hospitality POS… CISION PRNewswireJanuary 19, 2026
Press Release New Year's Resolution for Families: Supporting Children's Eye Health at Home SYDNEY, Jan. 19, 2026 /PRNewswire/ — As the new year begins, many… CISION PRNewswireJanuary 19, 2026
